HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2003
4901	4901 Tang XW, Wu DP, Sun AN, Zhu ZL, Ruan CG Sequential and quantitative analysis of chimerism after nonmyeloablative stem cell transplantation: Results of a single center study. BLOOD. 2003 NOV 16; 102 (11): 470B-470B	0	0	0	0
4902	4902 Pecora AL, Hsu JW, Goldberg SL, Siegel DS, Preti RA, et al. T-cell add-back at the time of related and unrelated multi-antigen HLA mismatched pan-T-cell depleted transplant results in donor chimerism and immune reconstitution without significant graft-versus-host disease. BLOOD. 2003 NOV 16; 102 (11): 479B-479B	0	0	0	0
4903	4903 Miyakoshi S, Kami M, Yuji K, Murashige N, Kusumi E, et al. Rapid engraftment and achievement of complete donor chimerism in adult patients with hematological disease following unrelated umbilical cord blood transplantation using a reduced-intensity conditioning (RI-UCBT). BLOOD. 2003 NOV 16; 102 (11): 480A-480A	0	0	0	0
4904	4904 Jaroscak JJ, Schwartz S, Laughlin MJ, Gerson SL Peripheral blood and bone marrow chimerism results in recipients of multiple umbilical cord blood transplant using short tandem repeat assays. BLOOD. 2003 NOV 16; 102 (11): 480A-480A	0	0	0	0
4905	4905 Ichinohe T, Uchiyama T, Shimazaki C, Tamaki S, Watanabe A, et al. Outcome of non-T-cell-depleted hematopoietic stem cell transplantation between HLA-haploidentical non-inherited maternal antigen(NIMA)-mismatched family members linked with long-term feto-maternal microchimerism. BLOOD. 2003 NOV 16; 102 (11): 485A-485A	0	0	0	0
4906	4906 Shimazaki C, Ochiai N, Yamada N, Uchida R, Fuchida S, et al. Non-T-cell depleted HLA 2 or 3 loci mismatched haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal microchimerism. BLOOD. 2003 NOV 16; 102 (11): 485A-485A	0	0	0	0
4907	4907 Yoshihara T, Morimoto A, Ishida H, Kuroda H, Maruya E, et al. Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on feto-maternal microchimerism in pediatric hematological malignancies. BLOOD. 2003 NOV 16; 102 (11): 485A-486A	0	0	0	0
4908	4908 Vasir B, Rosenblatt J, Wu ZW, Mcdermott D, Joyce R, et al. Dendritic cell chimerism and function following nonmyeloablative allogeneic stem cell transplantation. BLOOD. 2003 NOV 16; 102 (11): 695A-695A	0	0	0	0
4909	4909 Rubio MT, Zhao GL, Kattleman K, Sykes M Mechanisms of donor graft rejection and antitumor effects induced by recipient leukocyte infusion in mixed chimeras prepared with nonmyeloablative conditioning: Differential roles of recipient CD4 and CD8 T cells. BLOOD. 2003 NOV 16; 102 (11): 699A-699A	0	0	0	0
4910	4910 Chandy M, Poonkuzhali B, Shaji RV, Kumar S, George B, et al. Stable mixed chimerism following allogeneic bone marrow transplantation for thalassemia occurs mainly with low levels of recipient hematopoiesis. BLOOD. 2003 NOV 16; 102 (11): 704A-704A	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4911	4911 Yoshimi A, Niemeyer CM, Bohmer V, Strahm B, Kratz CP, et al. Chimerism analyses and subsequential immunological intervention after stem cell transplantation (SCT) in patients with juvenile myelomonocytic leukemia (JMML). BLOOD. 2003 NOV 16; 102 (11): 706A-706A	0	1	0	0
4912	4912 de Lima M, Carrasco A, Lee MS, Saliba R, Glassman A, et al. Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). BLOOD. 2003 NOV 16; 102 (11): 707A-707A	0	0	0	0
4913	4913 Furst S, Le QH, Praire A, Michallet AS, Nicolini F, et al. Is chimerism analysis after conventional and reduced intensity conditioning allogeneic hematopoetic stem cell transplantation a good marker of early relapse detection posttransplant? BLOOD. 2003 NOV 16; 102 (11): 724A-724A	0	0	0	0
4914	4914 Wu CJ, Rogers SA, Kutok JL, Hochberg EP, Biernacki M, et al. Erythroid chimerism in peripheral blood exceeds bone marrow following non-myeloablative stem cell transplantation in adults with sickle cell anemia. BLOOD. 2003 NOV 16; 102 (11): 763A-763A	0	0	0	0
4915	4915 Barge RMY, Marijt EWA, Osanto S, Starrenburg I, Smit WM, et al. Depleted non-myeloablative stem cell transplantation induces rapid conversion to full donor chimerism in patients with high risk malignancies. BLOOD. 2003 NOV 16; 102 (11): 969A-969A	0	0	0	0
4916	4916 Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma JOURNAL OF EXPERIMENTAL MEDICINE. 2003 NOV 17; 198 (10): 1475-1485	0	70	1	60
4917	4917 Schuler T, Kornig S, Blankenstein T Tumor rejection by modulation of tumor stromal fibroblasts JOURNAL OF EXPERIMENTAL MEDICINE. 2003 NOV 17; 198 (10): 1487-1493	0	26	0	45
4918	4918 Thiele J, Varus E, Wickenhauser C, Kvasnicka HM, Weirauch K, et al. Mixed chimerism of thyroid follicle cells after allogeneic bone marrow transplantation TRANSPLANTATION. 2003 NOV 27; 76 (10): 1532-1533	0	0	3	6
4919	4919 Tseng SB, Lin SF, Chang CS, Liu TC, Hsiao HH, et al. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation AMERICAN JOURNAL OF HEMATOLOGY. 2003 DEC; 74 (4): 273-275	0	3	0	10
4920	4920 Westgren L, Anneren G, Axelsson O, Evald U, Leblanc K, et al. Donor chimerism across full allogenic barriers achieved by in utero transplantation of fetal mesenchymal stem cells in a case of osteogenesis imperfecta AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003 DEC; 189 (6): S215-S215	1	1	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4921	4921 Shields L, Gaur L, Andrews R The use of mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003 DEC; 189 (6): S223-S223	0	0	0	0
4922	4922 Taguchi Y, Mohri S, Ironside JW, Muramoto T, Kitamoto T Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions AMERICAN JOURNAL OF PATHOLOGY. 2003 DEC; 163 (6): 2585-2593	0	22	1	29
4923	4923 Jones TR, Adams AB, Shirasugi NJ, Bingaman AW, Durham MM, et al. Allogeneic Parenchymal and hematopoietic tissues differ in their ability to induce deletion of donor-reactive T cells AMERICAN JOURNAL OF TRANSPLANTATION. 2003 DEC; 3 (12): 1520-1530	2	4	9	44
4924	4924 Park SS, Kim J, Brandts JF, Hong HJ Stability of murine, chimeric and humanized antibodies against pre-S2 surface antigen of hepatitis B virus BIOLOGICALS. 2003 DEC; 31 (4): 295-302	0	1	2	27
4925	4925 Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, et al. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-Cell reconstitution BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 DEC; 9 (12): 742-752	0	9	2	43
4926	4926 Chan GW, Foss FM, Klein AK, Sprague K, Miller KB Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 DEC; 9 (12): 753-759	2	18	8	26
4927	4927 Solomon A, Weiss DT, Wall JS Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2003 DEC; 18 (6): 853-860	1	33	1	74
4928	4928 Davis PH, Stanley SL Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases CELLULAR MICROBIOLOGY. 2003 DEC; 5 (12): 849-860	2	14	10	117
4929	4929 Kircher B, Latzer K, Gastl G, Nachbaur D Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003 DEC; 134 (3): 426-430	3	17	6	31
4930	4930 Nakajima H, Oki M, Kishi K, Ueyama JI, Miyakoshi S, et al. Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies CLINICAL AND LABORATORY HAEMATOLOGY. 2003 DEC; 25 (6): 383-391	1	3	14	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
4931	4931 Eakin GS, Behringer RR Tetraploid development in the mouse DEVELOPMENTAL DYNAMICS. 2003 DEC; 228 (4): 751-766	0	33	2	137
4932	4932 Niemeyer GP, Boudreaux MK, Goodman-Martin SA, Monroe CM, Wilcox DA, et al. Correction of a large animal model of type I Glanzmann's thrombasthenia by nonmyeloablative bone marrow transplantation EXPERIMENTAL HEMATOLOGY. 2003 DEC; 31 (12): 1357-1362	5	8	16	33
4933	4933 Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB The balance of deletion and regulation in allograft tolerance IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 75-84	6	56	17	71
4934	4934 Adams AB, Pearson TC, Larsen CP Heterologous immunity: an overlooked barrier to tolerance IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 147-160	24	96	33	106
4935	4935 Kirk AD Crossing the bridge: large animal models in translational transplantation research IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 176-196	14	53	49	212
4936	4936 Knechtle SJ Clinical trials: where are we now? IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 237-246	0	5	16	55
4937	4937 Jones SC, Murphy GF, Friedman TM, Korngold R Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4(+) T cell-mediated graft-versus-host disease model JOURNAL OF CLINICAL INVESTIGATION. 2003 DEC; 112 (12): 1880-1886	2	33	5	50
4938	4938 Brown RL, Lynch LL, Haley TL, Arsanjani R Pseudechetoxin binds to the pore turret of cyclic nucleotide-gated ion channels JOURNAL OF GENERAL PHYSIOLOGY. 2003 DEC; 122 (6): 749-760	0	21	0	51
4939	4939 Ikehara S A new concept of stem cell disorders and their new therapy JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. 2003 DEC; 12 (6): 643-653	2	16	5	32
4940	4940 Lee GW, Lee JH, Kim SB, Yu ES, Lee JL, et al. Membranous glomerulopathy as a manifestation of chronic graft-versus-host-disease after non-myeloablative stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria JOURNAL OF KOREAN MEDICAL SCIENCE. 2003 DEC; 18 (6): 901-904	1	9	4	23
#	Date / Author / Journal	LCS	GCS	LCR	CR
4941	4941 Woodard P, Tong X, Richardson S, Srivastava DK, Horwitz EM, et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2003 DEC; 25 (12): 955-959	3	11	7	27
4942	4942 Kasow KA, Handgretinger R, Krasin MJ, Pappo AS, Leung W Possible allogeneic graft-versus-tumor effect in childhood melanoma JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2003 DEC; 25 (12): 982-986	0	4	2	10
4943	4943 Scott LM, Priestley GV, Papayannopoulou T Deletion of alpha 4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing MOLECULAR AND CELLULAR BIOLOGY. 2003 DEC; 23 (24): 9349-9360	5	130	0	75
4944	4944 Mora L, Zavialov A, Ehrenberg M, Buckingham RH Stop codon recognition and interactions with peptide release factor RF3 of truncated and chimeric RF1 and RF2 from Escherichia coli MOLECULAR MICROBIOLOGY. 2003 DEC; 50 (5): 1467-1476	0	29	0	36
4945	4945 Pearl JP, Preston E, Kirk AD Tolerance: is it achievable in pediatric solid organ transplantation? PEDIATRIC CLINICS OF NORTH AMERICA. 2003 DEC; 50 (6): 1261-+	3	7	26	107
4946	4946 Kleinclauss F, Bittard H, Perruche S, de Carvalho-Bittencourt M, Chalopin JM, et al. Tolerance in transplantation: potential contribution of haematopoietic transplantation and cell therapy PROGRES EN UROLOGIE. 2003 DEC; 13 (6): 1406-1414	1	2	16	76
4947	4947 Aguillon JC, Contreras J, Dotte A, Cruzat A, Catalan D, et al. Biological therapy based on the use of last generation monoclonal antibodies REVISTA MEDICA DE CHILE. 2003 DEC; 131 (12): 1445-1453	0	6	0	40
4948	4948 Manfroi S, Bontadini A, Bonifazi F, Bandini G, Conte R Hematopoietic mixed chimerism after allogeneic BMT TRANSFUSION. 2003 DEC; 43 (12): 1758-1759	1	1	1	5
4949	4949 Baron PW, Weissman J, Ojogho ON, Sahney S, Cutler D, et al. Use of basiliximab with mycophenolate mofetil in kidney transplantation TRANSPLANTATION PROCEEDINGS. 2003 DEC; 35 (8): 2881-2884	0	1	3	6
4950	4950 Jin YZ, Zhang QY, Xie SS Low-dose donor bone marrow cells and splenocytes plus adenovirus encoding for CTLA4Ig gene promote stable mixed chimerism and long-term survival of rat cardiac allografts TRANSPLANTATION PROCEEDINGS. 2003 DEC; 35 (8): 3156-3159	3	3	4	5
#	Date / Author / Journal	LCS	GCS	LCR	CR
4951	4951 Deeg HJ, Gooley TA, Flowers MED, Sale GE, Slattery JT, et al. Allogeneic hematopoietic stem cell transplantation for myelofibrosis BLOOD. 2003 DEC 1; 102 (12): 3912-3918	12	115	4	32
4952	4952 Koh CY, Ortaldo JR, Blazar BR, Bennett M, Murphy WJ NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade BLOOD. 2003 DEC 1; 102 (12): 4067-4075	1	19	0	68
4953	4953 Roback JD, Hossain MS, Lezhava L, Gorechlad JW, Alexander SA, et al. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation JOURNAL OF IMMUNOLOGY. 2003 DEC 1; 171 (11): 6023-6031	3	16	3	37
4954	4954 Kean LS, Manci EA, Perry J, Balkan C, Coley S, et al. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease BLOOD. 2003 DEC 15; 102 (13): 4582-4593	12	28	9	30
4955	4955 Prabhune KA, Gorantla VS, Perez-Abadia G, Francois CG, Vossen M, et al. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model TRANSPLANTATION. 2003 DEC 15; 76 (11): 1548-1555	22	26	19	30
4956	4956 Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts TRANSPLANTATION. 2003 DEC 15; 76 (11): 1625-1627	0	5	2	7
4957	4957 Hu YH, Davison F, Zhang ZY, Xu QB Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells CIRCULATION. 2003 DEC 23; 108 (25): 3122-3127	4	115	4	35
4958	4958 Siemionow MZ, Izycki DM, Zielinski M Donor-specific tolerance in fully major histocompatibility complex-mismatched limb allograft transplants under an anti-alpha beta T-cell receptor monoclonal antibody and cyclosporine A protocol TRANSPLANTATION. 2003 DEC 27; 76 (12): 1662-1668	27	44	12	34
4959	4959 Baron F, Schaaf-Lafontaine N, Humblet-Baron S, Meuris N, Castermans E, et al. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation TRANSPLANTATION. 2003 DEC 27; 76 (12): 1705-1713	8	16	10	30
4960	4960 Akst LM, Siemionow M, Dan O, Izycki D, Strome M Induction of tolerance in a rat model of laryngeal transplantation TRANSPLANTATION. 2003 DEC 27; 76 (12): 1763-1766	4	14	1	8
#	Date / Author / Journal	LCS	GCS	LCR	CR
2004
4961	4961 Thiede C, Bornhauser M, Ehninger G Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation ACTA HAEMATOLOGICA. 2004; 112 (1-2): 16-23	19	22	50	70
4962	4962 Trakhtenbrot L, Rechavi G, Amariglio N The multiparametric scanning system for evaluation of minimal residual disease in hematological malignancies ACTA HAEMATOLOGICA. 2004; 112 (1-2): 24-29	0	11	4	28
4963	4963 Matz M, Beyer J, Wunsch D, Schoenemann C, Volk HD, et al. Presence of DNA-chimerism in urine of renal transplant recipients: A kinetic study. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 162-162	0	0	0	0
4964	4964 Camirand G, Rousseau J, Ducharme ME, Tremblay J, Rothstein D Tolerance to myoblast transplantation (MT) requires a novel protocol (anti-CD45RB, anti-CD154 and mixed chimerism) that promotes tolerance through persistence of peripheral and central mechanisms. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 187-187	0	0	0	0
4965	4965 Adams AB, Shirasugi N, Jones TR, Strobert E, Durham MM, et al. Blockade of the CD40-CD154 pathway using a chimeric anti-human CD40 monoclonal antibody synergized with CD28 blockade to prolong islet allograft survival. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 292-292	0	1	0	0
4966	4966 Mengel M, Jonigk D, Kleeberger W, Gwinner W, Haller H, et al. Tubular chimerism occurs regularly in renal allografts and is not related to the outcome. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 312-312	0	0	0	0
4967	4967 Metzler B, Gfeller P, Bigaud M, Li JP, Wieczorek G, et al. Combining LFA-1 blockade with everolimus or CD40L blockade for allogeneic bone marrow transplantation induces hematopoietic chimerism and central tolerance to solid tissues in mice. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 328-328	0	0	0	0
4968	4968 Koyama I, Kawai T, Wee SL, Boskovic S, Nadazdin O, et al. Development of a mixed chimerism-tolerance inducing nonmyeloablative regimen relevant to cadaver donor transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 330-330	0	0	0	0
4969	4969 Junge G, Hartl T, Nagy M, Neumann U, Neuhaus R, et al. Aspects of spontaneous microchimerism after orthotopic liver transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 362-362	0	0	0	0
4970	4970 Wang DH, Shi QX, Hadley GA, Farber DL, Bartlett ST Donor T-cell chimerism is associated with abrogation of recurrent autoimmunity in islet grafted NOD mice. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 468-468	0	1	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4971	4971 Liu BL, Pan YS, Heuss N, Sutherland DER, Hering BJ, et al. Loss of donor islet grafts in diabetic NOD mice with a low level of donor chimerism is mediated by autoinimunity. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 472-472	0	1	0	0
4972	4972 Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, et al. Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mismatched transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 491-491	0	0	0	0
4973	4973 Milas ZL, Adams AB, Jones T, Durham M, Pearson TC, et al. Anti-CD40 ligand antibody and anti-CD40 isotype IgG(2B) antibody induce equivalent murine chimerism and skin graft tolerance unlike anti-CD40 isotype IgG(1) antibody. AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 581-581	0	0	0	0
4974	4974 Rastetter W, Molina A, White CA Rituximab: Expanding role in therapy for lymphornas and autoimmune diseases ANNUAL REVIEW OF MEDICINE. 2004; 55: 477-503	2	126	4	143
4975	4975 Oluwole SF, Oluwole AO, Adeyeri AO, DePaz HA New strategies in immune tolerance induction CELL BIOCHEMISTRY AND BIOPHYSICS. 2004; : 27-48	0	0	23	131
4976	4976 [Anonymous] Induction of lymphocyte microchimerism does not prevent islet allograft loss in rats CELL BIOCHEMISTRY AND BIOPHYSICS. 2004; : 253-253	0	0	0	0
4977	4977 Costa C, Pizzolato MC, Shen YM, Wang Y, Fodor WL CD86 blockade in genetically modified porcine cells delays xenograft rejection by inhibiting T-cell and NK-cell activation CELL TRANSPLANTATION. 2004; 13 (1): 75-87	0	8	3	38
4978	4978 Warden S, Zaleske DJ, Glowacki J Fate of a chimeric joint construct in an ectopic site in SCID mice CELL TRANSPLANTATION. 2004; 13 (2): 161-168	0	6	0	15
4979	4979 Mas VR, Maluf DG, Thompson M, Ferreira-Gonzalez A, Fisher RA Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis CELL TRANSPLANTATION. 2004; 13 (3): 231-236	1	19	8	12
4980	4980 Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, et al. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration CELL TRANSPLANTATION. 2004; 13 (6): 659-666	2	44	10	25
#	Date / Author / Journal	LCS	GCS	LCR	CR
4981	4981 van Gelder T, Warle M, ter Meulen RG Anti-interleukin-2 receptor antibodies in transplantation - What is the basis for choice? DRUGS. 2004; 64 (16): 1737-1741	0	14	8	31
4982	4982 Jones DRE In utero stem cell transplantation: A European overview FETAL DIAGNOSIS AND THERAPY. 2004; 19 (3): 207-211	0	0	9	33
4983	4983 Touraine JL, Raudrant D, Golfier F, Rebaud A, Sembeil R, et al. Reappraisal of in utero stem cell transplantation based on long-term results FETAL DIAGNOSIS AND THERAPY. 2004; 19 (4): 305-312	8	14	10	28
4984	4984 Hutter G, Nickenig C, Garritsen H, Hellenkamp F, Hoerning A, et al. Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines HEMATOLOGY JOURNAL. 2004; 5 (1): 61-68	0	2	1	27
4985	4985 Kriz J, Saudek F, Girman P, Novota P Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: Failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS. 2004; 26 (3-4): 75-83	1	4	12	25
4986	4986 Turco AE, Bambara L Pregnancy, microchimerism and autoimmunity: an update LUPUS. 2004; 13 (9): 659-660	0	1	4	9
4987	4987 Alisky JM Xenografts are an achievable breakthrough MEDICAL HYPOTHESES. 2004; 63 (1): 92-97	0	3	12	56
4988	4988 Siemionow M, Ulusal BG, Ozmen S, Ulusal AE, Ozer K Composite vascularized skin/bone graft model: A viable source for vascularized bone marrow transplantation MICROSURGERY. 2004; 24 (3): 200-206	18	27	13	43
4989	4989 Ozer K, Izycki D, Zielinski M, Siemionow M Development of donor-specific chimerism and tolerance in composite tissue allografts under alpha beta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols MICROSURGERY. 2004; 24 (3): 248-254	12	15	4	30
4990	4990 Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GvHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion STEM CELLS. 2004; 22 (2): 125-134	10	30	15	39
#	Date / Author / Journal	LCS	GCS	LCR	CR
4991	4991 Zhang PL, Chebath J, Lonai P, Revel M Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gpl30 signaling STEM CELLS. 2004; 22 (3): 344-354	1	11	1	52
4992	4992 Nagy KZ, Laufs S, Gentner B, Naundorf S, Kuehlcke K, et al. Clonal analysis of individual marrow-repopulating cells after experimental peripheral blood progenitor cell transplantation STEM CELLS. 2004; 22 (4): 570-579	0	10	3	31
4993	4993 Fan TX, Hisha H, Jin TN, Sugiura K, Inaba M, et al. Induction of tolerance in quadruple chimeric mice STEM CELLS. 2004; 22 (5): 683-695	1	1	9	30
4994	4994 Shields LE, Gaur L, Delio P, Potter J, Sieverkropp A, et al. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates STEM CELLS. 2004; 22 (5): 759-769	9	15	23	48
4995	4995 Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, et al. Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair STEM CELLS. 2004; 22 (5): 812-822	5	145	3	21
4996	4996 Xu H, Exner BG, Chilton PM, Schanie C, Ildstad ST CD45 congenic bone marrow transplantation: Evidence for T cell-mediated immunity STEM CELLS. 2004; 22 (6): 1039-1048	2	10	16	32
4997	4997 Sherwood RI, Christensen JL, Weissman IL, Wagers AJ Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells STEM CELLS. 2004; 22 (7): 1292-1304	2	52	6	39
4998	4998 Vinogradova ON, Savchenko VG, Domracheva EV, Parovichnikova EN, Dyachenko LV, et al. Leukemic transformation of donor cells: Is it possible? TERAPEVTICHESKII ARKHIV. 2004; 76 (7): 28-34	0	0	5	21
4999	4999 Nydegger UE Nature bundles immunoglobulin iso-, allo- and idiotype to target adaptive immune response TRANSFUSION MEDICINE AND HEMOTHERAPY. 2004; 31 (3): 143-150	0	1	0	30
5000	5000 Arndt PA, Garratty G Flow cytofluorometric analysis in red blood cell immunology TRANSFUSION MEDICINE AND HEMOTHERAPY. 2004; 31 (3): 163-174	0	6	4	136

Date / Author / Journal

LCS

GCS

LCR

2003

4901

4901 Tang XW, Wu DP, Sun AN, Zhu ZL, Ruan CG

Sequential and quantitative analysis of chimerism after nonmyeloablative stem cell transplantation: Results of a single center study.

BLOOD. 2003 NOV 16; 102 (11): 470B-470B

4902

4902 Pecora AL, Hsu JW, Goldberg SL, Siegel DS, Preti RA, et al.

T-cell add-back at the time of related and unrelated multi-antigen HLA mismatched pan-T-cell depleted transplant results in donor chimerism and immune reconstitution without significant graft-versus-host disease.

BLOOD. 2003 NOV 16; 102 (11): 479B-479B

4903

4903 Miyakoshi S, Kami M, Yuji K, Murashige N, Kusumi E, et al.BLOOD. 2003 NOV 16; 102 (11): 480A-480A

4904

4904 Jaroscak JJ, Schwartz S, Laughlin MJ, Gerson SL

Peripheral blood and bone marrow chimerism results in recipients of multiple umbilical cord blood transplant using short tandem repeat assays.

BLOOD. 2003 NOV 16; 102 (11): 480A-480A

4905

4905 Ichinohe T, Uchiyama T, Shimazaki C, Tamaki S, Watanabe A, et al.

Outcome of non-T-cell-depleted hematopoietic stem cell transplantation between HLA-haploidentical non-inherited maternal antigen(NIMA)-mismatched family members linked with long-term feto-maternal microchimerism.

BLOOD. 2003 NOV 16; 102 (11): 485A-485A

4906

4906 Shimazaki C, Ochiai N, Yamada N, Uchida R, Fuchida S, et al.

Non-T-cell depleted HLA 2 or 3 loci mismatched haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal microchimerism.

BLOOD. 2003 NOV 16; 102 (11): 485A-485A

4907

4907 Yoshihara T, Morimoto A, Ishida H, Kuroda H, Maruya E, et al.

Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on feto-maternal microchimerism in pediatric hematological malignancies.

BLOOD. 2003 NOV 16; 102 (11): 485A-486A

4908

4908 Vasir B, Rosenblatt J, Wu ZW, Mcdermott D, Joyce R, et al.

Dendritic cell chimerism and function following nonmyeloablative allogeneic stem cell transplantation.

BLOOD. 2003 NOV 16; 102 (11): 695A-695A

4909

4909 Rubio MT, Zhao GL, Kattleman K, Sykes M

Mechanisms of donor graft rejection and antitumor effects induced by recipient leukocyte infusion in mixed chimeras prepared with nonmyeloablative conditioning: Differential roles of recipient CD4 and CD8 T cells.

BLOOD. 2003 NOV 16; 102 (11): 699A-699A

4910

4910 Chandy M, Poonkuzhali B, Shaji RV, Kumar S, George B, et al.

Stable mixed chimerism following allogeneic bone marrow transplantation for thalassemia occurs mainly with low levels of recipient hematopoiesis.

BLOOD. 2003 NOV 16; 102 (11): 704A-704A

Date / Author / Journal

LCS

GCS

LCR

4911

4911 Yoshimi A, Niemeyer CM, Bohmer V, Strahm B, Kratz CP, et al.

Chimerism analyses and subsequential immunological intervention after stem cell transplantation (SCT) in patients with juvenile myelomonocytic leukemia (JMML).

BLOOD. 2003 NOV 16; 102 (11): 706A-706A

4912

4912 de Lima M, Carrasco A, Lee MS, Saliba R, Glassman A, et al.

Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

BLOOD. 2003 NOV 16; 102 (11): 707A-707A

4913

4913 Furst S, Le QH, Praire A, Michallet AS, Nicolini F, et al.

Is chimerism analysis after conventional and reduced intensity conditioning allogeneic hematopoetic stem cell transplantation a good marker of early relapse detection posttransplant?

BLOOD. 2003 NOV 16; 102 (11): 724A-724A

4914

4914 Wu CJ, Rogers SA, Kutok JL, Hochberg EP, Biernacki M, et al.

Erythroid chimerism in peripheral blood exceeds bone marrow following non-myeloablative stem cell transplantation in adults with sickle cell anemia.

BLOOD. 2003 NOV 16; 102 (11): 763A-763A

4915

4915 Barge RMY, Marijt EWA, Osanto S, Starrenburg I, Smit WM, et al.

Depleted non-myeloablative stem cell transplantation induces rapid conversion to full donor chimerism in patients with high risk malignancies.

BLOOD. 2003 NOV 16; 102 (11): 969A-969A

4916

4916 Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP

Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma

JOURNAL OF EXPERIMENTAL MEDICINE. 2003 NOV 17; 198 (10): 1475-1485

4917

4917 Schuler T, Kornig S, Blankenstein T

Tumor rejection by modulation of tumor stromal fibroblasts

JOURNAL OF EXPERIMENTAL MEDICINE. 2003 NOV 17; 198 (10): 1487-1493

4918

4918 Thiele J, Varus E, Wickenhauser C, Kvasnicka HM, Weirauch K, et al.

Mixed chimerism of thyroid follicle cells after allogeneic bone marrow transplantation

TRANSPLANTATION. 2003 NOV 27; 76 (10): 1532-1533

4919

4919 Tseng SB, Lin SF, Chang CS, Liu TC, Hsiao HH, et al.

Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation

AMERICAN JOURNAL OF HEMATOLOGY. 2003 DEC; 74 (4): 273-275

4920

4920 Westgren L, Anneren G, Axelsson O, Evald U, Leblanc K, et al.

Donor chimerism across full allogenic barriers achieved by in utero transplantation of fetal mesenchymal stem cells in a case of osteogenesis imperfecta

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003 DEC; 189 (6): S215-S215

Date / Author / Journal

LCS

GCS

LCR

4921

4921 Shields L, Gaur L, Andrews R

The use of mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003 DEC; 189 (6): S223-S223

4922

4922 Taguchi Y, Mohri S, Ironside JW, Muramoto T, Kitamoto T

Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions

AMERICAN JOURNAL OF PATHOLOGY. 2003 DEC; 163 (6): 2585-2593

4923

4923 Jones TR, Adams AB, Shirasugi NJ, Bingaman AW, Durham MM, et al.

Allogeneic Parenchymal and hematopoietic tissues differ in their ability to induce deletion of donor-reactive T cells

AMERICAN JOURNAL OF TRANSPLANTATION. 2003 DEC; 3 (12): 1520-1530

4924

4924 Park SS, Kim J, Brandts JF, Hong HJ

Stability of murine, chimeric and humanized antibodies against pre-S2 surface antigen of hepatitis B virus

BIOLOGICALS. 2003 DEC; 31 (4): 295-302

4925

4925 Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, et al.

Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-Cell reconstitution

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 DEC; 9 (12): 742-752

4926

4926 Chan GW, Foss FM, Klein AK, Sprague K, Miller KB

Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 DEC; 9 (12): 753-759

4927

4927 Solomon A, Weiss DT, Wall JS

Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2003 DEC; 18 (6): 853-860

4928

4928 Davis PH, Stanley SL

Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases

CELLULAR MICROBIOLOGY. 2003 DEC; 5 (12): 849-860

117

4929

4929 Kircher B, Latzer K, Gastl G, Nachbaur D

Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003 DEC; 134 (3): 426-430

4930

4930 Nakajima H, Oki M, Kishi K, Ueyama JI, Miyakoshi S, et al.

Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies

CLINICAL AND LABORATORY HAEMATOLOGY. 2003 DEC; 25 (6): 383-391

Date / Author / Journal

LCS

GCS

LCR

4931

4931 Eakin GS, Behringer RR

Tetraploid development in the mouse

DEVELOPMENTAL DYNAMICS. 2003 DEC; 228 (4): 751-766

137

4932

4932 Niemeyer GP, Boudreaux MK, Goodman-Martin SA, Monroe CM, Wilcox DA, et al.

Correction of a large animal model of type I Glanzmann's thrombasthenia by nonmyeloablative bone marrow transplantation

EXPERIMENTAL HEMATOLOGY. 2003 DEC; 31 (12): 1357-1362

4933

4933 Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB

The balance of deletion and regulation in allograft tolerance

IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 75-84

4934

4934 Adams AB, Pearson TC, Larsen CP

Heterologous immunity: an overlooked barrier to tolerance

IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 147-160

106

4935

4935 Kirk AD

Crossing the bridge: large animal models in translational transplantation research

IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 176-196

212

4936

4936 Knechtle SJ

Clinical trials: where are we now?

IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 237-246

4937

4937 Jones SC, Murphy GF, Friedman TM, Korngold R

Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4(+) T cell-mediated graft-versus-host disease model

JOURNAL OF CLINICAL INVESTIGATION. 2003 DEC; 112 (12): 1880-1886

4938

4938 Brown RL, Lynch LL, Haley TL, Arsanjani R

Pseudechetoxin binds to the pore turret of cyclic nucleotide-gated ion channels

JOURNAL OF GENERAL PHYSIOLOGY. 2003 DEC; 122 (6): 749-760

4939

4939 Ikehara S

A new concept of stem cell disorders and their new therapy

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. 2003 DEC; 12 (6): 643-653

4940

4940 Lee GW, Lee JH, Kim SB, Yu ES, Lee JL, et al.

Membranous glomerulopathy as a manifestation of chronic graft-versus-host-disease after non-myeloablative stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

JOURNAL OF KOREAN MEDICAL SCIENCE. 2003 DEC; 18 (6): 901-904

Date / Author / Journal

LCS

GCS

LCR

4941

4941 Woodard P, Tong X, Richardson S, Srivastava DK, Horwitz EM, et al.

Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2003 DEC; 25 (12): 955-959

4942

4942 Kasow KA, Handgretinger R, Krasin MJ, Pappo AS, Leung W

Possible allogeneic graft-versus-tumor effect in childhood melanoma

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2003 DEC; 25 (12): 982-986

4943

4943 Scott LM, Priestley GV, Papayannopoulou T

Deletion of alpha 4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing

MOLECULAR AND CELLULAR BIOLOGY. 2003 DEC; 23 (24): 9349-9360

130

4944

4944 Mora L, Zavialov A, Ehrenberg M, Buckingham RH

Stop codon recognition and interactions with peptide release factor RF3 of truncated and chimeric RF1 and RF2 from Escherichia coli

MOLECULAR MICROBIOLOGY. 2003 DEC; 50 (5): 1467-1476

4945

4945 Pearl JP, Preston E, Kirk AD

Tolerance: is it achievable in pediatric solid organ transplantation?

PEDIATRIC CLINICS OF NORTH AMERICA. 2003 DEC; 50 (6): 1261-+

107

4946

4946 Kleinclauss F, Bittard H, Perruche S, de Carvalho-Bittencourt M, Chalopin JM, et al.

Tolerance in transplantation: potential contribution of haematopoietic transplantation and cell therapy

PROGRES EN UROLOGIE. 2003 DEC; 13 (6): 1406-1414

4947

4947 Aguillon JC, Contreras J, Dotte A, Cruzat A, Catalan D, et al.

Biological therapy based on the use of last generation monoclonal antibodies

REVISTA MEDICA DE CHILE. 2003 DEC; 131 (12): 1445-1453

4948

4948 Manfroi S, Bontadini A, Bonifazi F, Bandini G, Conte R

Hematopoietic mixed chimerism after allogeneic BMT

TRANSFUSION. 2003 DEC; 43 (12): 1758-1759

4949

4949 Baron PW, Weissman J, Ojogho ON, Sahney S, Cutler D, et al.

Use of basiliximab with mycophenolate mofetil in kidney transplantation

TRANSPLANTATION PROCEEDINGS. 2003 DEC; 35 (8): 2881-2884

4950

4950 Jin YZ, Zhang QY, Xie SS

Low-dose donor bone marrow cells and splenocytes plus adenovirus encoding for CTLA4Ig gene promote stable mixed chimerism and long-term survival of rat cardiac allografts

TRANSPLANTATION PROCEEDINGS. 2003 DEC; 35 (8): 3156-3159

Date / Author / Journal

LCS

GCS

LCR

4951

4951 Deeg HJ, Gooley TA, Flowers MED, Sale GE, Slattery JT, et al.

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

BLOOD. 2003 DEC 1; 102 (12): 3912-3918

115

4952

4952 Koh CY, Ortaldo JR, Blazar BR, Bennett M, Murphy WJ

NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade

BLOOD. 2003 DEC 1; 102 (12): 4067-4075

4953

4953 Roback JD, Hossain MS, Lezhava L, Gorechlad JW, Alexander SA, et al.

Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation

JOURNAL OF IMMUNOLOGY. 2003 DEC 1; 171 (11): 6023-6031

4954

4954 Kean LS, Manci EA, Perry J, Balkan C, Coley S, et al.

Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease

BLOOD. 2003 DEC 15; 102 (13): 4582-4593

4955

4955 Prabhune KA, Gorantla VS, Perez-Abadia G, Francois CG, Vossen M, et al.

Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model

TRANSPLANTATION. 2003 DEC 15; 76 (11): 1548-1555

4956

4956 Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, et al.

Donor origin of de novo hepatocellular carcinoma in hepatic allografts

TRANSPLANTATION. 2003 DEC 15; 76 (11): 1625-1627

4957

4957 Hu YH, Davison F, Zhang ZY, Xu QB

Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells

CIRCULATION. 2003 DEC 23; 108 (25): 3122-3127

115

4958

4958 Siemionow MZ, Izycki DM, Zielinski M

Donor-specific tolerance in fully major histocompatibility complex-mismatched limb allograft transplants under an anti-alpha beta T-cell receptor monoclonal antibody and cyclosporine A protocol

TRANSPLANTATION. 2003 DEC 27; 76 (12): 1662-1668

4959

4959 Baron F, Schaaf-Lafontaine N, Humblet-Baron S, Meuris N, Castermans E, et al.

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

TRANSPLANTATION. 2003 DEC 27; 76 (12): 1705-1713

4960

4960 Akst LM, Siemionow M, Dan O, Izycki D, Strome M

Induction of tolerance in a rat model of laryngeal transplantation

TRANSPLANTATION. 2003 DEC 27; 76 (12): 1763-1766

Date / Author / Journal

LCS

GCS

LCR

2004

4961

4961 Thiede C, Bornhauser M, Ehninger G

Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation

ACTA HAEMATOLOGICA. 2004; 112 (1-2): 16-23

4962

4962 Trakhtenbrot L, Rechavi G, Amariglio N

The multiparametric scanning system for evaluation of minimal residual disease in hematological malignancies

ACTA HAEMATOLOGICA. 2004; 112 (1-2): 24-29

4963

4963 Matz M, Beyer J, Wunsch D, Schoenemann C, Volk HD, et al.

Presence of DNA-chimerism in urine of renal transplant recipients: A kinetic study.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 162-162

4964

4964 Camirand G, Rousseau J, Ducharme ME, Tremblay J, Rothstein D

Tolerance to myoblast transplantation (MT) requires a novel protocol (anti-CD45RB, anti-CD154 and mixed chimerism) that promotes tolerance through persistence of peripheral and central mechanisms.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 187-187

4965

4965 Adams AB, Shirasugi N, Jones TR, Strobert E, Durham MM, et al.

Blockade of the CD40-CD154 pathway using a chimeric anti-human CD40 monoclonal antibody synergized with CD28 blockade to prolong islet allograft survival.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 292-292

4966

4966 Mengel M, Jonigk D, Kleeberger W, Gwinner W, Haller H, et al.

Tubular chimerism occurs regularly in renal allografts and is not related to the outcome.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 312-312

4967

4967 Metzler B, Gfeller P, Bigaud M, Li JP, Wieczorek G, et al.

Combining LFA-1 blockade with everolimus or CD40L blockade for allogeneic bone marrow transplantation induces hematopoietic chimerism and central tolerance to solid tissues in mice.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 328-328

4968

4968 Koyama I, Kawai T, Wee SL, Boskovic S, Nadazdin O, et al.

Development of a mixed chimerism-tolerance inducing nonmyeloablative regimen relevant to cadaver donor transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 330-330

4969

4969 Junge G, Hartl T, Nagy M, Neumann U, Neuhaus R, et al.

Aspects of spontaneous microchimerism after orthotopic liver transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 362-362

4970

4970 Wang DH, Shi QX, Hadley GA, Farber DL, Bartlett ST

Donor T-cell chimerism is associated with abrogation of recurrent autoimmunity in islet grafted NOD mice.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 468-468

Date / Author / Journal

LCS

GCS

LCR

4971

4971 Liu BL, Pan YS, Heuss N, Sutherland DER, Hering BJ, et al.

Loss of donor islet grafts in diabetic NOD mice with a low level of donor chimerism is mediated by autoinimunity.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 472-472

4972

4972 Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, et al.

Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mismatched transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 491-491

4973

4973 Milas ZL, Adams AB, Jones T, Durham M, Pearson TC, et al.

Anti-CD40 ligand antibody and anti-CD40 isotype IgG(2B) antibody induce equivalent murine chimerism and skin graft tolerance unlike anti-CD40 isotype IgG(1) antibody.

AMERICAN JOURNAL OF TRANSPLANTATION. 2004; 4: 581-581

4974

4974 Rastetter W, Molina A, White CA

Rituximab: Expanding role in therapy for lymphornas and autoimmune diseases

ANNUAL REVIEW OF MEDICINE. 2004; 55: 477-503

126

143

4975

4975 Oluwole SF, Oluwole AO, Adeyeri AO, DePaz HA

New strategies in immune tolerance induction

CELL BIOCHEMISTRY AND BIOPHYSICS. 2004; : 27-48

131

4976

4976 [Anonymous]

Induction of lymphocyte microchimerism does not prevent islet allograft loss in rats

CELL BIOCHEMISTRY AND BIOPHYSICS. 2004; : 253-253

4977

4977 Costa C, Pizzolato MC, Shen YM, Wang Y, Fodor WL

CD86 blockade in genetically modified porcine cells delays xenograft rejection by inhibiting T-cell and NK-cell activation

CELL TRANSPLANTATION. 2004; 13 (1): 75-87

4978

4978 Warden S, Zaleske DJ, Glowacki J

Fate of a chimeric joint construct in an ectopic site in SCID mice

CELL TRANSPLANTATION. 2004; 13 (2): 161-168

4979

4979 Mas VR, Maluf DG, Thompson M, Ferreira-Gonzalez A, Fisher RA

Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis

CELL TRANSPLANTATION. 2004; 13 (3): 231-236

4980

4980 Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, et al.

Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration

CELL TRANSPLANTATION. 2004; 13 (6): 659-666

Date / Author / Journal

LCS

GCS

LCR

4981

4981 van Gelder T, Warle M, ter Meulen RG

Anti-interleukin-2 receptor antibodies in transplantation - What is the basis for choice?

DRUGS. 2004; 64 (16): 1737-1741

4982

4982 Jones DRE

In utero stem cell transplantation: A European overview

FETAL DIAGNOSIS AND THERAPY. 2004; 19 (3): 207-211

4983

4983 Touraine JL, Raudrant D, Golfier F, Rebaud A, Sembeil R, et al.

Reappraisal of in utero stem cell transplantation based on long-term results

FETAL DIAGNOSIS AND THERAPY. 2004; 19 (4): 305-312

4984

4984 Hutter G, Nickenig C, Garritsen H, Hellenkamp F, Hoerning A, et al.

Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines

HEMATOLOGY JOURNAL. 2004; 5 (1): 61-68

4985

4985 Kriz J, Saudek F, Girman P, Novota P

Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: Failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model

INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS. 2004; 26 (3-4): 75-83

4986

4986 Turco AE, Bambara L

Pregnancy, microchimerism and autoimmunity: an update

LUPUS. 2004; 13 (9): 659-660

4987

4987 Alisky JM

Xenografts are an achievable breakthrough

MEDICAL HYPOTHESES. 2004; 63 (1): 92-97

4988

4988 Siemionow M, Ulusal BG, Ozmen S, Ulusal AE, Ozer K

Composite vascularized skin/bone graft model: A viable source for vascularized bone marrow transplantation

MICROSURGERY. 2004; 24 (3): 200-206

4989

4989 Ozer K, Izycki D, Zielinski M, Siemionow M

Development of donor-specific chimerism and tolerance in composite tissue allografts under alpha beta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols

MICROSURGERY. 2004; 24 (3): 248-254

4990

4990 Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, et al.

Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GvHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion

STEM CELLS. 2004; 22 (2): 125-134

Date / Author / Journal

LCS

GCS

LCR

4991

4991 Zhang PL, Chebath J, Lonai P, Revel M

Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gpl30 signaling

STEM CELLS. 2004; 22 (3): 344-354

4992

4992 Nagy KZ, Laufs S, Gentner B, Naundorf S, Kuehlcke K, et al.

Clonal analysis of individual marrow-repopulating cells after experimental peripheral blood progenitor cell transplantation

STEM CELLS. 2004; 22 (4): 570-579

4993

4993 Fan TX, Hisha H, Jin TN, Sugiura K, Inaba M, et al.

Induction of tolerance in quadruple chimeric mice

STEM CELLS. 2004; 22 (5): 683-695

4994

4994 Shields LE, Gaur L, Delio P, Potter J, Sieverkropp A, et al.

Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates

STEM CELLS. 2004; 22 (5): 759-769

4995

4995 Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, et al.

Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair

STEM CELLS. 2004; 22 (5): 812-822

145

4996

4996 Xu H, Exner BG, Chilton PM, Schanie C, Ildstad ST

CD45 congenic bone marrow transplantation: Evidence for T cell-mediated immunity

STEM CELLS. 2004; 22 (6): 1039-1048

4997

4997 Sherwood RI, Christensen JL, Weissman IL, Wagers AJ

Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells

STEM CELLS. 2004; 22 (7): 1292-1304

4998

4998 Vinogradova ON, Savchenko VG, Domracheva EV, Parovichnikova EN, Dyachenko LV, et al.

Leukemic transformation of donor cells: Is it possible?

TERAPEVTICHESKII ARKHIV. 2004; 76 (7): 28-34

4999

4999 Nydegger UE

Nature bundles immunoglobulin iso-, allo- and idiotype to target adaptive immune response

TRANSFUSION MEDICINE AND HEMOTHERAPY. 2004; 31 (3): 143-150

5000

5000 Arndt PA, Garratty G

Flow cytofluorometric analysis in red blood cell immunology

TRANSFUSION MEDICINE AND HEMOTHERAPY. 2004; 31 (3): 163-174

136

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records